The latest in NET News
The need for tumor tissue in NETs The Neuroendocrine Tumor Research Foundation is on a
David Van Bibber calls his neuroendocrine cancer diagnosis a blessing in disguise.it. Since his 2010 diagnosis at the age of 32, David’s priorities and perspectives have changed. As a result, he has invested more deeply in his health, his family, and his community. Now he is reaping the rewards of that investment and finding daily joy in his life.
There is a critical need to develop improved diagnostic tools for non-invasive, early detection of NETs in a broader range of patients. New grant-funded research will work towards this goal.
Patients and caregivers discuss lessons learned on their journey.
Patients and physicians discuss the importance of finding a specialist.
Search for NET specialists
Find NET doctors, treatment programs, and support groups near you
Follow us on social media.
13National Cancer Institute. Pheochromocytoma and paraganglioma treatment (PDQ®)-patient version. 2017. https://www.cancer.gov/types/pheochromocytoma/patient/pheochromocytoma-treatment-pdq. Accessed October 23, 2018.
14Wolin EM, Leyden J, Goldstein G, et al. Patient-reported experience of diagnosis, management, and burden of neuroendocrine tumors: results from a large patient survey in the U.S. Pancreas.2017; 16(5):639-647.